News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
151,293 Results
Type
Article (9130)
Company Profile (20)
Press Release (142142)
Multimedia
Podcasts (11)
Webinars (3)
Section
Business (35807)
Career Advice (250)
Deals (6015)
Drug Delivery (30)
Drug Development (24945)
Employer Resources (15)
FDA (4602)
Job Trends (3367)
News (71447)
Policy (6467)
Tag
Academia (614)
Accelerated approval (7)
Adcomms (8)
Allergies (50)
Alliances (9732)
ALS (16)
Alzheimer's disease (498)
Antibody-drug conjugate (ADC) (29)
Approvals (4781)
Artificial intelligence (102)
Autoimmune disease (71)
Automation (3)
Bankruptcy (56)
Best Places to Work (3060)
Biosimilars (70)
Biotechnology (21)
Bladder cancer (28)
Brain cancer (9)
Breast cancer (58)
Cancer (789)
Cardiovascular disease (171)
Career advice (212)
Career pathing (1)
CAR-T (63)
CDC (6)
Celiac Disease (1)
Cell therapy (177)
Cervical cancer (3)
Clinical research (22634)
Collaboration (374)
Compensation (118)
Complete response letters (10)
COVID-19 (457)
CRISPR (36)
C-suite (168)
Cystic fibrosis (72)
Data (2166)
Decentralized trials (1)
Denatured (5)
Depression (38)
Diabetes (231)
Diagnostics (1257)
Digital health (9)
Diversity (4)
Diversity, equity & inclusion (5)
Drug discovery (61)
Drug pricing (42)
Drug shortages (11)
Duchenne muscular dystrophy (69)
Earnings (14586)
Editorial (10)
Employer branding (3)
Employer resources (15)
Events (23028)
Executive appointments (239)
FDA (5630)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (6)
Funding (382)
Gene editing (63)
Generative AI (8)
Gene therapy (123)
GLP-1 (373)
Government (828)
Grass and pollen (2)
Guidances (110)
Healthcare (4035)
HIV (26)
Huntington's disease (5)
IgA nephropathy (46)
Immunology and inflammation (132)
Immuno-oncology (6)
Indications (31)
Infectious disease (529)
Inflammatory bowel disease (105)
Inflation Reduction Act (3)
Influenza (14)
Intellectual property (80)
Interviews (50)
IPO (2988)
IRA (7)
Job creations (494)
Job search strategy (152)
JPM (19)
Kidney cancer (3)
Labor market (6)
Layoffs (114)
Leadership (2)
Legal (931)
Liver cancer (25)
Longevity (8)
Lung cancer (98)
Lymphoma (140)
Machine learning (8)
Management (6)
Manufacturing (157)
MASH (109)
Medical device (3085)
Medtech (3097)
Mergers & acquisitions (3299)
Metabolic disorders (581)
Multiple sclerosis (82)
NASH (12)
Neurodegenerative disease (66)
Neuropsychiatric disorders (26)
Neuroscience (842)
NextGen: Class of 2026 (1443)
Non-profit (1207)
Obesity (243)
Opinion (43)
Ovarian cancer (8)
Pain (132)
Pancreatic cancer (27)
Parkinson's disease (80)
Partnered (8)
Patents (132)
Patient recruitment (151)
Peanut (8)
People (11053)
Pharmaceutical (4)
Pharmacy benefit managers (5)
Phase 1 (5925)
Phase 2 (10109)
Phase 3 (8182)
Pipeline (1654)
Policy (54)
Postmarket research (858)
Preclinical (2215)
Press Release (4)
Prostate cancer (36)
Psychedelics (5)
Radiopharmaceuticals (58)
Rare diseases (285)
Real estate (748)
Recruiting (5)
Regulatory (6069)
Reports (13)
Research institute (625)
Resumes & cover letters (57)
Rett syndrome (2)
RNA editing (4)
RSV (33)
Schizophrenia (64)
Series A (66)
Series B (46)
Sickle cell disease (37)
Special edition (4)
Spinal muscular atrophy (50)
Sponsored (9)
Startups (752)
Supply chain (20)
Tariffs (16)
The Weekly (6)
Vaccines (143)
Venture capital (13)
Weight loss (156)
Women's health (20)
Worklife (1)
Date
Last 7 days (163)
Last 30 days (516)
Last 365 days (7972)
2026 (724)
2025 (8133)
2024 (9510)
2023 (10106)
2022 (14214)
2021 (14536)
2020 (12774)
2019 (10972)
2018 (8059)
2017 (7665)
2016 (7239)
2015 (8175)
2014 (5755)
2013 (4255)
2012 (4423)
2011 (4386)
2010 (3866)
Location
Africa (130)
Alabama (9)
Alaska (3)
Arizona (49)
Arkansas (1)
Asia (7520)
Australia (1672)
California (2983)
Canada (764)
China (320)
Colorado (166)
Connecticut (115)
Delaware (145)
Europe (22529)
Florida (481)
Georgia (134)
Hawaii (1)
Idaho (13)
Illinois (144)
India (16)
Indiana (176)
Iowa (3)
Japan (146)
Kansas (43)
Kentucky (12)
Louisiana (9)
Maine (12)
Maryland (371)
Massachusetts (2089)
Michigan (67)
Minnesota (120)
Mississippi (1)
Missouri (15)
Montana (11)
Nebraska (4)
Nevada (60)
New Hampshire (42)
New Jersey (813)
New Mexico (6)
New York (807)
North Carolina (454)
North Dakota (1)
Northern California (1683)
Ohio (67)
Oklahoma (7)
Oregon (11)
Pennsylvania (623)
Puerto Rico (5)
Rhode Island (11)
South America (155)
South Carolina (8)
South Dakota (1)
Southern California (950)
Tennessee (28)
Texas (397)
United States (10395)
Utah (86)
Vermont (1)
Virginia (81)
Washington D.C. (7)
Washington State (129)
Wisconsin (26)
151,293 Results for "chr hansen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.
January 29, 2024
·
8 min read
Deals
Novozymes and Chr. Hansen announce name of future combined company; Novonesis
Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis will unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
December 13, 2023
·
13 min read
Press Releases
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
May 21, 2025
·
4 min read
Press Releases
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary effective immediately
May 21, 2025
·
4 min read
Business
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.
February 6, 2024
·
8 min read
Deals
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/ Denmark , to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein Biotechnologie, the innovation a
September 22, 2020
·
4 min read
Business
LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors
LIfT BioSciences, a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, announces the appointments of Dr Bo Rode Hansen PhD, MBA and Dr Marco Gottardis, PhD as Non-Executive Directors of its Board.
December 21, 2023
·
4 min read
Deals
UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.
July 28, 2020
·
3 min read
Bergen Prepares to Host International Conference on Hansen’s Disease Marking 150 Years Since the Discovery of the Leprosy Bacillus
The Sasakawa Leprosy (Hansen’s Disease) Initiative and the University of Bergen are organizing a two-day conference in Bergen, Norway, on June 21-22, 2023, to commemorate the 150 th anniversary of the discovery of M. leprae , the causative agent of leprosy, in 1873.
June 19, 2023
·
4 min read
Business
Prota Therapeutics Partners With World Leading Bioscience Company, Chr. Hansen
Prota Therapeutics partners with leading global bioscience company, Chr. Hansen, to progress the development of oral immunotherapies to treat food allergies. The partnership will assess the world’s best documented probiotic strain LGG® in a Phase III clinical trial to develop a treatment for peanut allergy.
April 18, 2018
·
4 min read
1 of 15,130
Next